Trials / Completed
CompletedNCT02730104
Community-based Neuroendocrine Tumor (NET) Research Study
Prospective Observational Study in Patients With Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated With Lanreotide Depot in a US Community Oncology Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to assess time to disease progression of patients with locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors treated with Lanreotide Depot. This is an observational study therefore all data collected will be in accordance with the routine practice of physicians.
Conditions
Timeline
- Start date
- 2015-11-23
- Primary completion
- 2020-05-13
- Completion
- 2020-05-13
- First posted
- 2016-04-06
- Last updated
- 2020-06-26
Locations
12 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02730104. Inclusion in this directory is not an endorsement.